A team of scientists at Oxford University have reported a more accurate and less invasive test to diagnose mesothelioma. The findings have been reported in a recent edition of the American Journal of Respiratory and Critical Care Medicine.
The test is claimed to be quicker and more accurate in testing for mesothelioma. Since it involves pleural fluid cytology the serum mesothelium is utilized as a bio marker to establish a diagnosis of mesothelioma.
The scientists indicate that the quick test will allow injured workers to file claims with greater reliability. Dr. Helen Davies, who participated in the research project stated, "Claims for worker's compensation may also be instigated once the diagnosis is confirmed."
Mesothelioma is a fatal disease that is associated with exposure to asbestos fiber. It is tumor that grows on the linings of the lungs or abdomen. Many workers have been exposed over the decades to asbestos and have developed mesothelioma in epidemic proportions.
Exposure to asbestos may occur as a result of both direct exposure to asbestos in the workplace or though a secondary exposure as a bystander or even a household contact of an asbestos workers. The disease has a very long latency period of the date of exposure to the date of manifestation. Asbestos, a known human carcinogen, use has not yet been banned in the United States.
For more information about treatment options, potential claims for benefits and the history of asbestos production, please visit out web site www.gelmans.com.
No comments:
Post a Comment